BORRBangladesh Open Research Repository
SearchSubmitAboutContact
BORRResearch for a Better Bangladesh.
AboutSubmit PaperContactTermsPolicyGitHub

© 2026 Bangladesh Open Research Repository.

Filters

Sort By

Sort by relevanceSort by dateSort by citations
Year Range
to

Results for “"S. M. Zahid Hosen"”

16+ results

In silico-based vaccine design against Ebola virus glycoprotein

Verified

Raju Dash, Rasel Das, Md. Junaid, Md. Forhad Chowdhury Akash et al.

Journal: Advances and Applications in Bioinformatics and ChemistryYear: 2017Citations: 89

Ebola virus (EBOV) is one of the lethal viruses, causing more than 24 epidemic outbreaks to date. Despite having available molecular knowledge of this virus, no definite vaccine or other remedial agents have been developed yet for the management and avoidance of EBOV infections in humans. Disclosing...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Structural and Dynamic Characterizations Highlight the Deleterious Role of SULT1A1 R213H Polymorphism in Substrate Binding

Verified

Raju Dash, Md. Chayan Ali, Nayan Dash, Md. Abul Kalam Azad et al.

Journal: International Journal of Molecular SciencesYear: 2019Citations: 83

Sulfotransferase 1A1 (SULT1A1) is responsible for catalyzing various types of endogenous and exogenous compounds. Accumulating data indicates that the polymorphism rs9282861 (R213H) is responsible for inefficient enzymatic activity and associated with cancer progression. To characterize the detailed...

Physical SciencesChemistrySpectroscopyOpen Access
Read Source

Structure-based identification of potent VEGFR-2 inhibitors from in vivo metabolites of a herbal ingredient

Verified

Raju Dash, Md. Junaid, Sarmistha Mitra, Md. Arifuzzaman et al.

Journal: Journal of Molecular ModelingYear: 2019Citations: 50

Vascular endothelial growth factor receptor-2 (VEGFR-2) is one of the regulatory elements of angiogenesis that is expressed highly in various diseases and is also essential for solid tumor growth. The present study was aimed at identifying potent inhibitors of VEGFR-2 by considering herbal secondary...

Life SciencesPharmacology, Toxicology and PharmaceuticsToxicology
Read Source

Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU)

Verified

S. M. Zahid Hosen, Md. Nazim Uddin, Zhihong Xu, Benjamin J. Buckley et al.

Journal: Frontiers in ImmunologyYear: 2022Citations: 48

Background Previous studies have revealed the role of dysregulated urokinase plasminogen activator (encoded by PLAU ) expression and activity in several pathways associated with cancer progression. However, systematic investigation into the association of PLAU expression with factors that modulate P...

Health SciencesMedicineOncologyOpen Access
Read Source

Adhatoda vasica (Nees.): A Review on its Botany, Traditional uses, Phytochemistry, Pharmacological Activities and Toxicity

Verified

Tahmida Shamsuddin, Muhammad Shaiful Alam, Md. Junaid, Rasheda Akter et al.

Journal: Mini-Reviews in Medicinal ChemistryYear: 2021Citations: 42

BACKGROUND: Adhatoda vasica (Nees.) of the family Acanthaceae has been used in the Southeast tropical zone as it is efficacious against headache, colds, cough, whooping cough, fever, asthma, dyspnea, phthisis, jaundice, chronic bronchitis, and diarrhea. It exhibits commendable pharmacological activi...

Life SciencesBiochemistry, Genetics and Molecular BiologyMolecular Biology
Read Source

Design of novel viral attachment inhibitors of the spike glycoprotein (S) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) through virtual screening and dynamics

Verified

Arafat Rahman Oany, Mamun Mia, Tahmina Pervin, Md. Junaid et al.

Journal: International Journal of Antimicrobial AgentsYear: 2020Citations: 30

To date, the global COVID-19 pandemic has been associated with 11.8 million cases and over 545481 deaths. In this study, we have employed virtual screening approaches and selected 415 lead-like compounds from 103 million chemical substances, based on the existing drugs, from PubChem databases as pot...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

A Comprehensive Review on Linum usitatissimum Medicinal Plant: Its Phytochemistry, Pharmacology, and Ethnomedicinal Uses

Verified

Yeasmin Akter, Md. Junaid, Syeda Samira Afrose, Afsana Nahrin et al.

Journal: Mini-Reviews in Medicinal ChemistryYear: 2021Citations: 29

BACKGROUND: Linum usitatissimum or flax has been broadly utilized in numerous milieus worldwide as a primeval medicinal plant because of its health benefits in diverse types of diseases. OBJECTIVE: The objective of this review is to assemble the latest information on the botanical description, distr...

Health SciencesMedicinePathology and Forensic Medicine
Read Source

Molecular docking analysis of known flavonoids as duel COX-2 inhibitors in the context of cancer

Verified

Raju Dash, Mir Muhammad Nasir Uddin, S. M. Zahid Hosen, Zahed Bin Rahim et al.

Journal: BioinformationYear: 2015Citations: 28

Cyclooxygenase-2 (COX-2) catalyzed synthesis of prostaglandin E2 and it associates with tumor growth, infiltration, and metastasis in preclinical experiments. Known inhibitors against COX-2 exhibit toxicity. Therefore, it is of interest to screen natural compounds like flavanoids against COX-2. Mole...

Health SciencesMedicinePharmacologyOpen Access
Read Source

Whole proteome screening and identification of potential epitopes of SARS-CoV-2 for vaccine design-an immunoinformatic, molecular docking and molecular dynamics simulation accelerated robust strategy

Verified

Md. Muzahid Ahmed Ezaj, Md. Junaid, Yeasmin Akter, Afsana Nahrin et al.

Journal: Journal of Biomolecular Structure and DynamicsYear: 2021Citations: 27

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the most cryptic pandemic outbreak of the 21st century, has gripped more than 1.8 million people to death and infected almost eighty six million. As it is a new variant of SARS, there is no approved drug or vaccine available against this ...

Life SciencesBiochemistry, Genetics and Molecular BiologyMolecular Biology
Read Source

Unveiling the Structural Insights into the Selective Inhibition of Protein Kinase D1

Verified

Raju Dash, Md. Arifuzzaman, Sarmistha Mitra, Md. Abdul Hannan et al.

Journal: Current Pharmaceutical DesignYear: 2019Citations: 26

BACKGROUND: Although protein kinase D1 (PKD1) has been proved to be an efficient target for anticancer drug development, lack of structural details and substrate binding mechanisms are the main obstacles for the development of selective inhibitors with therapeutic benefits. OBJECTIVE: The present st...

Life SciencesBiochemistry, Genetics and Molecular BiologyMolecular Biology
Read Source

In silico analysis of indole-3-carbinol and its metabolite DIM as EGFR tyrosine kinase inhibitors in platinum resistant ovarian cancer vis a vis ADME/T property analysis

Verified

Raju Dash, S. M. Zahid Hosen, Md. Rezaul Karim, Mohammad Shah Hafez Kabir et al.

Journal: Journal of Applied Pharmaceutical ScienceYear: 2015Citations: 26

Epidermal Growth Factor Receptor (EGFR) is one of the four members of the Human Epidermal Receptor (HER) family, which is deregulated and over expressed in platinum resistant ovarian cancer. Thus, targeting EGFR receptor along with platinum drugs is one of the major strategies to increase the platin...

Physical SciencesChemistryOrganic ChemistryOpen Access
Read Source

In silico ADME/T and 3D QSAR analysis of KDR inhibitors

Verified

S. M. Zahid Hosen, Raju Dash, Mahmuda Khatun, Rasheda Akter et al.

Journal: Journal of Applied Pharmaceutical ScienceYear: 2017Citations: 24

Tyrosine kinases (KDR) have been considered as a potential targets for the design of new anticancer agents. Recently, a series of N-4-chlorophenylnaphthamides has been reported with KDR inhibitory activity. In order to demonstrate the pharmacokinetics and the relationship between the structures and ...

Health SciencesMedicineRadiology, Nuclear Medicine and ImagingOpen Access
Read Source

Identification and structural characterization of deleterious non-synonymous single nucleotide polymorphisms in the human SKP2 gene

Verified

S. M. Zahid Hosen, Raju Dash, Md. Junaid, Sarmistha Mitra et al.

Journal: Computational Biology and ChemistryYear: 2019Citations: 22

In SCF (Skp, Cullin, F-box) ubiquitin-protein ligase complexes, S-phase kinase 2 (SKP2) is one of the major players of F-box family, that is responsible for the degradation of several important cell regulators and tumor suppressor proteins. Despite of having significant evidence for the role of SKP2...

Life SciencesBiochemistry, Genetics and Molecular BiologyMolecular Biology
Read Source

Brassica oleracea var. capitata f. alba: A Review on its Botany, Traditional uses, Phytochemistry and Pharmacological Activities

Verified

Lipi Rani Ray, Muhammad Shaiful Alam, Md. Junaid, Sakia Ferdousy et al.

Journal: Mini-Reviews in Medicinal ChemistryYear: 2021Citations: 21

BACKGROUND: Brassica oleracea var. capitata f. alba (white cabbage) is a cruciferous vegetable used as a vegetable and traditional medicine all over the world. Different preparation from several parts of the plant- roots, shoots, leaves, and the whole plant are used to treat a wide range of diseases...

Life SciencesBiochemistry, Genetics and Molecular BiologyMolecular Biology
Read Source

Molecular simulation studies to reveal the binding mechanisms of shikonin derivatives inhibiting VEGFR-2 kinase

Verified

Yeasmin Akter Munni, Md. Chayan Ali, Nusrat Jahan Selsi, Marium Sultana et al.

Journal: Computational Biology and ChemistryYear: 2020Citations: 19

Traditional vascular endothelial growth factor receptor 2 (VEGFR-2) inhibitors can manage angiogenesis; however, severe toxicity and resistance limit their long-term applications in clinical therapy. Shikonin (SHK) and its derivatives could be promising to inhibit the VEGFR-2 mediated angiogenesis, ...

Life SciencesPharmacology, Toxicology and PharmaceuticsToxicology
Read Source
PreviousPage 1 of 2+Next